Stock Track | Critical Metals Corporation Plummets 8.39% in Pre-market Following Major Shareholder's Stock Sale

Stock Track
Oct 17, 2025

Critical Metals Corporation (NASDAQ: CRML) experienced a sharp 8.39% pre-market plunge on Friday, continuing its downward trend from the previous trading session. The significant drop comes in the wake of news that European Lithium, a major shareholder, sold 3.03 million shares of CRML at $16.50 per share.

The sell-off by European Lithium appears to have sparked concerns among investors, leading to increased selling pressure in the pre-market hours. This comes on the heels of Thursday's trading session, where CRML had already declined by 5.56% despite announcing a $50 million private investment in public equity (PIPE) financing deal earlier that day.

Market sentiment towards CRML seems to have soured rapidly. The initial positive reaction to the PIPE financing, which was intended to fund the development of the company's Tanbreez rare earth deposit in Greenland, quickly gave way to concerns over potential share dilution. The deal involves issuing approximately 1.47 million new ordinary shares and pre-funded warrants for an additional 1.56 million shares. The subsequent sale of shares by European Lithium has likely exacerbated these concerns, contributing to the current pre-market plunge. Investors appear to be reassessing the long-term impact of these developments on CRML's stock value and future prospects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10